These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2533994)

  • 1. [Value of ipratropium (Atrovent) in the treatment of chronic obstructive lung diseases in myasthenic patients treated with anticholinesterase agents. Apropos of a case].
    Robinet G; Leroyer C; Andre J; Dewitte JD; Clavier J
    Rev Pneumol Clin; 1989; 45(4):161-3. PubMed ID: 2533994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipratropium in patients with COPD receiving cholinesterase inhibitors.
    Liggett SB; Daughaday CC; Senior RM
    Chest; 1988 Jul; 94(1):210-2. PubMed ID: 2968227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Atrovent (ipratropium bromide) on the mechanics of respiration in patients with chronic obstructive pulmonary disease].
    Malinowski R; Frank-Piskorska A; Wasek Z; Koczorowski T
    Pneumonol Pol; 1986 Mar; 54(3):91-5. PubMed ID: 2942842
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bronchial obstruction--therapy with ipratropium bromide. Results of a multicenter clinical study].
    Stauder J; Flasch CI
    Fortschr Med; 1988 Oct; 106(31):631-4. PubMed ID: 2972596
    [No Abstract]   [Full Text] [Related]  

  • 5. Ipratropium: an alternative for bronchodilator therapy.
    Lynn MM; Holdcroft C
    Nurse Pract; 1990 May; 15(5):44-8. PubMed ID: 2140435
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of the bronchodilatating effects of ipratropium and terbutalin inhaled with Monaghan IPPB-M 515 by 19 patients with chronic obstructive airways disease.
    Petersen BN; Weeke E
    Scand J Respir Dis Suppl; 1979; 103():178-82. PubMed ID: 155295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol.
    Ashutosh K; Lang H
    Ann Allergy; 1984 Nov; 53(5):401-6. PubMed ID: 6238558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical comparison of Atrovent and a placebo in patients with chronic obstructive lung diseases].
    Lien JT
    Tidsskr Nor Laegeforen; 1980 Jul; 100(19-21):1193-5. PubMed ID: 6448492
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):130-55. PubMed ID: 138352
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of Berotec, Atrovent and Becotide on histamine-induced bronchial spasm in patients with chronic bronchitis].
    Kurgan J
    Pneumonol Pol; 1983 Nov; 51(11):561-8. PubMed ID: 6229720
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of salbutamol and ipratropium in chronic bronchitis and chronic airflow limitation.
    Barnes D; Delaney JC
    Br J Clin Pract; 1988 Sep; 42(9):372-6. PubMed ID: 2978246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term atrovent treatment of chronic obstructive bronchitis].
    Simanenkov VI; Il'iashevich IG; Liparteliani BG; Ledovaia AV
    Ter Arkh; 1998; 70(9):77-9. PubMed ID: 9821235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative trial of ipratropium bromide (Atrovent), controlled release theophylline (Phyllocontin), and a combination of these in patients with reversible airflow obstruction.
    Sahay JN; Chatterjee SS; Summerfield PJ
    Br J Clin Pract; 1986 May; 40(5):198-202. PubMed ID: 2944533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of atrovent].
    Zamotaev IP; Maksimova LN
    Klin Med (Mosk); 1984 Apr; 62(4):50-4. PubMed ID: 6234428
    [No Abstract]   [Full Text] [Related]  

  • 15. Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.
    Pavia D; Bateman JR; Sheahan NF; Clarke SW
    Eur J Respir Dis; 1980 Oct; 61(5):245-53. PubMed ID: 6451446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis: protective effect of ipratropiumbromide (Atrovent) on airways obstruction caused by edrophonium chloride (Tensilon).
    Szathmáry I; Magyar P; Szobor A
    Eur Neurol; 1981; 20(1):56-61. PubMed ID: 6451430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy--a review of clinical studies.
    Rudolf M
    Postgrad Med J; 1984; 60 Suppl 1():9-12. PubMed ID: 6145152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value and limitations of salbutamol in the treatment of the obstructive syndrome. Comparative study with a synthetic atropine-like agent].
    Uffholtz H; Sadoul P; Lempereur L; Sentissi M
    Minerva Med; 1976 Mar; 67(15):917-21. PubMed ID: 131259
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined treatment with ipratropin and fenoterol in chronic obstructive lung disease].
    Langaker O
    Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):558-9. PubMed ID: 6218649
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of ipratropium bromide in obstructive lung disease.
    Mann KV; Leon AL; Tietze KJ
    Clin Pharm; 1988 Sep; 7(9):670-80. PubMed ID: 2977109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.